Work

NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

Year: 2018

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2018.08.051

Authors: A. Trotti, J. Harris, M. Gillison, A. Eisbruch, P.M. Harari, D.J. Adelstein, E.M. Sturgis, J.M. Galvin, S. Koyfman, D. Blakaj, M.A. Razaq, A.D. Colevas, J.J. Beitler, C.U. Jones, N.E. Dunlap, S.A. Seaward, S.A. Spencer, J.A. Ridge, J. Phan, Q.T. Le

Institutions: Moffitt Cancer Center, RTOG Foundation, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Wisconsin–Madison, Cleveland Clinic, The Ohio State University, Stanford University, Emory University, Sutter Health, Sutter Medical Center, University of Louisville Hospital, Kaiser Permanente, Kaiser Permanente Vallejo Medical Center, University of Alabama at Birmingham, Fox Chase Cancer Center, Stanford Cancer Institute

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2900517404

FWCI: 0.808

Cites:

Cited by: 6

Related to: 10